Visiopharm Competitors, Revenue, Alternatives and Pricing

Claim your profile


Hoersholm, DEN Denmark
Total Funding:N/A
Industry:Tech Services
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Visiopharm's estimated annual revenue is currently $15.1M per year.(?)
  • Visiopharm's estimated revenue per employee is $145,000

Employee Data

  • Visiopharm has 104 Employees.(?)
  • Visiopharm grew their employee count by 51% last year.
  • Visiopharm currently has 1 job openings.

Visiopharm is a world leader in Augmented Pathology solutions; quantitative image analysis and Digital Pathology, solving everything from H&E to advanced fluorescence. Leading biopharmaceutical companies, contract research organizations (CRO), academic medical centers, and hospital diagnostic pathology labs all over the world utilize the Oncotopix® platform for tissue-based research and diagnostics. Oncotopix® provides scientists and pathologist with a scalable software solution that fits the needs and volumes of both research and diagnostic labs. Over the past years, Visiopharm has grown into an international business with over 900 installations and countless more users. Visiopharm software is featured in over 1300 scientific publications since 2010 and is compatible with leading slide scanning systems and data management software. A growing network of authorized distributors and integration partners support the growth of Visiopharm solutions on several continents including North America, Europe, and Asia. Our headquarters is in the Medicon Valley of Denmark, with a branch office in the United Kingdom, and a North American office in Broomfield, Colorado.